跳至主要内容
临床试验/EUCTR2021-001391-42-AT
EUCTR2021-001391-42-AT进行中(未招募)1 期

Characterisation of the effects of Spermidine on the immune response to Covid-19 vaccine in older people - a feasibility study - Spermidine and Covid-19 vaccination in older people

Medical University of Graz0 个研究点目标入组 40 人开始时间: 2021年4月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Capacity to provide written informed consent
  • 2.Age =65 and <90 years at consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • 1.Incapacity to provide written informed consent
  • 2.Active signs or symptoms of acute infection at the time of screening
  • 3.Ongoing or previous SARS-CoV-2 vaccination
  • 4.Positive SARS-CoV-2 PCR in the past or during the study period.
  • 5.Glucocorticoid, immunosuppressive or other immune modifying therapy, current or within 3 months prior to first study visit
  • 6.Medical history of current or past human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C infection
  • 7.Receipt of blood, blood products and/or plasma derivatives or any immunoglobulin preparation, current or within 3 months prior to first study intervention
  • 8.Medical conditions that can suppress the immune system
  • 9.Any complicating medical issues or abnormal clinical laboratory results that may interfere with study conduct.
  • 10.History of liver insufficiency or laboratory evidence of liver dysfunction with aspartate transaminase (AST) or alanine transaminase (ALT) greater than 3 times the upper limits of normal
  • 11.Previous allergy to vaccinations or their constituent parts
  • 12.History of malignancies other than skin
  • 13.Hypersensitivity to Spermidine or to any of its excipients
  • 14.Gluten intolerance
  • 15.Contraindication to vaccination
  • 16.Use of any other investigational drug in the previous 30 days and/or intent on using any investigational drug for the duration of the trial
  • 17.Any condition that in the investigator's opinion may adversely affect study participation or may compromise the study results

研究者

发起方
Medical University of Graz

相似试验

已完成
不适用
Investigate the effects of a spermidine supplementation on immune system and inflammatory parameters in old and young adultsThe aim of our study is to investigate the effect of a short-term spermidine supplementation on inflammatory and immune system parameters as well as polyamine concentrations in blood of old and young adults.
DRKS00025879Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DIfE)40
招募中
3 期
Evaluation of the effect of Thiamine in the prevention of post-thrombotic syndrome in patients with deep vein thrombosis of the lower extremitiespost thrombotic syndrome.Postthrombotic syndromeI87.0
IRCT20221106056416N1Hamedan University of Medical Sciences80
已完成
2 期
Effects of S-medtomidine infusion on pro- and anti-inflammatory cytokines in pediatric open heart surgeryCondition 1: congenital heart diseases. Condition 2: Congenital malformations of cardiac septa. Condition 3: Congenital malformations of pulmonary and tricuspid valves. Condition 4: Congenital malformations of aortic and mitral valves.Congenital malformations of the circulatory systemCongenital malformations of cardiac septaCongenital malformations of pulmonary and tricuspid valvesCongenital malformations of aortic and mitral valvesQ20-Q28
IRCT2016061927617N2Vice chancellor for research, Iran University of Medical Sciences40
招募中
3 期
Effect of pyridostigmine in stroke-related dysphagia
IRCT20230520058232N1Sanandaj University of Medical Sciences60
招募中
3 期
Investigating the effects of Silymarin in the treatment of neonatal jaundice
IRCT20211122053144N1Mashhad University of Medical Sciences60